- Report
- January 2026
- 181 Pages
Global
From €3112EUR$3,545USD£2,722GBP
€3458EUR$3,939USD£3,025GBP
- Report
- January 2026
- 188 Pages
Global
From €3112EUR$3,545USD£2,722GBP
€3458EUR$3,939USD£3,025GBP
- Report
- October 2025
- 250 Pages
Global
From €3942EUR$4,490USD£3,448GBP
- Report
- October 2025
- 250 Pages
Global
From €3942EUR$4,490USD£3,448GBP
- Report
- September 2025
- 250 Pages
Global
From €3942EUR$4,490USD£3,448GBP
- Report
- February 2026
- 177 Pages
Global
From €5136EUR$5,850USD£4,492GBP
- Report
- February 2026
- 194 Pages
Global
From €5136EUR$5,850USD£4,492GBP
- Report
- February 2026
- 200 Pages
Global
From €7015EUR$7,990USD£6,136GBP
- Clinical Trials
- April 2025
- 240 Pages
Global
From €2634EUR$3,000USD£2,304GBP
- Drug Pipelines
- April 2025
- 180 Pages
Global
From €2195EUR$2,500USD£1,920GBP
- Report
- January 2026
- 185 Pages
Global
From €3951EUR$4,500USD£3,456GBP
- Report
- November 2025
- 185 Pages
Global
From €3951EUR$4,500USD£3,456GBP
- Report
- May 2025
- 196 Pages
Global
From €4170EUR$4,750USD£3,648GBP
- Report
- August 2025
- 136 Pages
Global
From €3511EUR$3,999USD£3,071GBP
- Report
- October 2025
- 160 Pages
Global
From €3468EUR$3,950USD£3,033GBP
- Report
- October 2025
- 100 Pages
United States
From €5224EUR$5,950USD£4,569GBP
- Report
- July 2025
- 82 Pages
United States
From €3073EUR$3,500USD£2,688GBP
- Report
- May 2025
- 120 Pages
Global
From €5224EUR$5,950USD£4,569GBP
- Report
- August 2025
- 183 Pages
Global
From €3112EUR$3,545USD£2,722GBP
€3458EUR$3,939USD£3,025GBP
- Report
- August 2025
- 184 Pages
Global
From €3112EUR$3,545USD£2,722GBP
€3458EUR$3,939USD£3,025GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more